- cafead   Jan 25, 2024 at 11:12: AM
via
article source
- Sarepta Therapeutics and Vertex Pharmaceuticals both go after rare diseases.
- Sarepta has made headway in its core area, but there is more work to be done.
- Even so, financial results for the more diminutive biotech have been encouraging.
article source